QJM Advance Access published online on April 13, 2006
QJM, doi:10.1093/qjmed/hcl041
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 From the University of Cambridge Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK
* To whom correspondence should be addressed. Background: The prevalence of obesity is rising, but little is known about its psychosocial correlates. Aim: To assess psychological co-morbidities and impairment of quality of life in obese individuals seeking treatment at two specialist centres in the UK. Design: Retrospective analysis of anthropometric and questionnaire data collected at initial clinic visit. Methods: Patients attending for a first visit between April 2004 and March 2005 completed questionnaires that included scales for measurement of anxiety and depression (Hospital Anxiety and Depression Scale), eating disorder-behaviour (Eating Disorder Inventory 2), assessment of body image (Body Image Assessment for Obesity) and quality of life (Impact of Weight on Quality of Life--Lite). We examined the relationships between variables measured on these scales and anthropometric data. Results: Of 253 questionnaires evaluated, there were elevated scores for depression in 48%, and elevated scores for anxiety in 56%. Twenty-two percent demonstrated scores suggestive of a personality trait that overlaps with an eating disorder; an additional 11.5% had an elevated score for bulimia. About a third of individuals had significant impaired quality of life in the areas of examined. Discussion: Psychological co-morbidities are common in obese individuals attending specialist weight-management clinics, and may merit consideration at (or before) commencement of a weight loss programme.
Received January 19, 2006
Accepted March 7, 2006
Original Papers
Psychiatric co-morbidities in patients attending specialist obesity services in the UK
A. Tuthill 1 *,
H. Slawik 2,
S. O’rahilly 1,
and
N. Finer 3
2 From the Department of Psychiatry, Addenbrooke's Hospital, Cambridge, UK
3 From the Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital, Cambridge, UK
A. Tuthill, E-mail: tt280{at}medschl.cam.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Less weight or more hype with {blacktriangledown}rimonabant? DTB, June 1, 2007; 45(6): 41 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gadde Effect of rimonabant on weight and cardiometabolic risk factors. JAMA, August 9, 2006; 296(6): 649 - 650. [Full Text] [PDF] |
||||

